Dot Compliance
Harness the power of AI for life sciences quality and compliance
Harness the power of AI for life sciences quality and compliance
Dot Compliance is a pioneering company in the **Information Technology** and **Pharmaceutical** industries, delivering the first ready-to-use, AI-powered eQMS for Life Sciences. Founded in **2007** and headquartered in the **United States**, Dot Compliance's slogan "Discover the Ready to Use, AI Powered QMS" reflects its innovative approach. The company's eQMS, packed with generative AI capabilities, empowers medical device manufacturers, biotechnology, and pharmaceutical companies to bring products to market faster and more cost-effectively. The most recent milestone for Dot Compliance is a significant **$17.50M Series B investment** on **15 April 2024**. The investors in this round, including **TPY Capital**, **Vertex Ventures**, and **Israel Growth Partners**, demonstrate notable confidence in the potential of Dot Compliance's solutions. This latest injection of capital is expected to further propel the company's advancements in AI-powered quality management systems, reinforcing its position as a key player in the life sciences industry.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series B | $17.50M | 3 |
|
15 Apr 2024 |
| Series B | $23.00M | 3 |
|
20 Jul 2022 |
| Series A | $10.00M | 2 |
|
21 Jan 2021 |
No recent news or press coverage available for Dot Compliance.
We care about your data, and we'd love to use cookies make your experience better.
